Cramer says although it's speculative, he is bullish on gene sequencing stock Guardant Health Inc (NASDAQ: GH).
He remains bullish on Berkshire Hathaway Inc. Class B (NYSE: BRK-B) and has been recommending the stock since the show began.
Seattle Genetics, Inc. (NASDAQ: SGEN) is a buy, says Cramer.
'Halftime Report' Final Trades From July 16: American Airlines, JetBlue And More
'Fast Money' Traders Talk Retail: Costco, Target And More
See more from Benzinga
- 'Trading Nation' Traders Talk Chipolte, McDonald's And Starbucks
- 3 Stocks Moving In Monday's After-Hours Session
- Whirlpool Reports Q2 Earnings Beat
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.